UFP TECHNOLOGIES INC (UFPT)

US9026731029 - Common Stock

252.85  +6.81 (+2.77%)

After market: 252.85 0 (0%)

Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to UFPT. UFPT was compared to 187 industry peers in the Health Care Equipment & Supplies industry. UFPT scores excellent on profitability, but there are some minor concerns on its financial health. UFPT is not overvalued while it is showing excellent growth. This is an interesting combination. This makes UFPT very considerable for growth investing!



8

1. Profitability

1.1 Basic Checks

UFPT had positive earnings in the past year.
UFPT had a positive operating cash flow in the past year.
In the past 5 years UFPT has always been profitable.
UFPT had a positive operating cash flow in each of the past 5 years.

1.2 Ratios

The Return On Assets of UFPT (8.49%) is better than 89.84% of its industry peers.
The Return On Equity of UFPT (16.47%) is better than 91.98% of its industry peers.
The Return On Invested Capital of UFPT (10.61%) is better than 91.44% of its industry peers.
UFPT had an Average Return On Invested Capital over the past 3 years of 9.40%. This is in line with the industry average of 8.19%.
The last Return On Invested Capital (10.61%) for UFPT is above the 3 year average (9.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 8.49%
ROE 16.47%
ROIC 10.61%
ROA(3y)8.98%
ROA(5y)8.8%
ROE(3y)13.83%
ROE(5y)12.26%
ROIC(3y)9.4%
ROIC(5y)9.46%

1.3 Margins

UFPT's Profit Margin of 11.74% is amongst the best of the industry. UFPT outperforms 88.24% of its industry peers.
In the last couple of years the Profit Margin of UFPT has grown nicely.
UFPT has a better Operating Margin (15.83%) than 86.63% of its industry peers.
UFPT's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 28.31%, UFPT is doing worse than 76.47% of the companies in the same industry.
In the last couple of years the Gross Margin of UFPT has grown nicely.
Industry RankSector Rank
OM 15.83%
PM (TTM) 11.74%
GM 28.31%
OM growth 3Y14.65%
OM growth 5Y5.97%
PM growth 3Y14.56%
PM growth 5Y8.39%
GM growth 3Y4.03%
GM growth 5Y2%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UFPT is creating some value.
UFPT has more shares outstanding than it did 1 year ago.
UFPT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for UFPT has been reduced compared to a year ago.

2.2 Solvency

UFPT has an Altman-Z score of 5.73. This indicates that UFPT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 5.73, UFPT belongs to the top of the industry, outperforming 81.28% of the companies in the same industry.
The Debt to FCF ratio of UFPT is 4.67, which is a neutral value as it means it would take UFPT, 4.67 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 4.67, UFPT belongs to the top of the industry, outperforming 82.35% of the companies in the same industry.
A Debt/Equity ratio of 0.61 indicates that UFPT is somewhat dependend on debt financing.
With a Debt to Equity ratio value of 0.61, UFPT is not doing good in the industry: 67.38% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.67
Altman-Z 5.73
ROIC/WACC1.16
WACC9.15%

2.3 Liquidity

UFPT has a Current Ratio of 2.57. This indicates that UFPT is financially healthy and has no problem in meeting its short term obligations.
With a Current ratio value of 2.57, UFPT perfoms like the industry average, outperforming 45.45% of the companies in the same industry.
A Quick Ratio of 1.43 indicates that UFPT should not have too much problems paying its short term obligations.
UFPT has a worse Quick ratio (1.43) than 63.10% of its industry peers.
Industry RankSector Rank
Current Ratio 2.57
Quick Ratio 1.43

7

3. Growth

3.1 Past

UFPT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 28.86%, which is quite impressive.
The Earnings Per Share has been growing by 22.74% on average over the past years. This is a very strong growth
Looking at the last year, UFPT shows a quite strong growth in Revenue. The Revenue has grown by 18.48% in the last year.
Measured over the past years, UFPT shows a quite strong growth in Revenue. The Revenue has been growing by 16.00% on average per year.
EPS 1Y (TTM)28.86%
EPS 3Y48.68%
EPS 5Y22.74%
EPS Q2Q%38.82%
Revenue 1Y (TTM)18.48%
Revenue growth 3Y30.65%
Revenue growth 5Y16%
Sales Q2Q%44.01%

3.2 Future

The Earnings Per Share is expected to grow by 19.49% on average over the next years. This is quite good.
The Revenue is expected to grow by 17.77% on average over the next years. This is quite good.
EPS Next Y29.29%
EPS Next 2Y22.31%
EPS Next 3Y19.49%
EPS Next 5YN/A
Revenue Next Year27.68%
Revenue Next 2Y22.86%
Revenue Next 3Y17.77%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.

4

4. Valuation

4.1 Price/Earnings Ratio

UFPT is valuated quite expensively with a Price/Earnings ratio of 36.07.
70.59% of the companies in the same industry are more expensive than UFPT, based on the Price/Earnings ratio.
UFPT's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.20.
With a Price/Forward Earnings ratio of 28.89, UFPT can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 75.40% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.73, UFPT is valued a bit more expensive.
Industry RankSector Rank
PE 36.07
Fwd PE 28.89

4.2 Price Multiples

UFPT's Enterprise Value to EBITDA ratio is a bit cheaper when compared to the industry. UFPT is cheaper than 74.33% of the companies in the same industry.
UFPT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UFPT is cheaper than 78.07% of the companies in the same industry.
Industry RankSector Rank
P/FCF 42.66
EV/EBITDA 24.8

4.3 Compensation for Growth

UFPT's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of UFPT may justify a higher PE ratio.
UFPT's earnings are expected to grow with 19.49% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.23
PEG (5Y)1.59
EPS Next 2Y22.31%
EPS Next 3Y19.49%

0

5. Dividend

5.1 Amount

No dividends for UFPT!.
Industry RankSector Rank
Dividend Yield N/A

UFP TECHNOLOGIES INC

NASDAQ:UFPT (12/20/2024, 8:00:01 PM)

After market: 252.85 0 (0%)

252.85

+6.81 (+2.77%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-05 2024-11-05/bmo
Earnings (Next)02-19 2025-02-19/amc
Inst OwnersN/A
Inst Owner Change3.26%
Ins OwnersN/A
Ins Owner Change-0.27%
Market Cap1.94B
Analysts80
Price Target388.62 (53.7%)
Short Float %10.43%
Short Ratio9.86
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)13.33%
Min EPS beat(2)12.38%
Max EPS beat(2)14.29%
EPS beat(4)4
Avg EPS beat(4)25.88%
Min EPS beat(4)12.38%
Max EPS beat(4)46.43%
EPS beat(8)7
Avg EPS beat(8)18.43%
EPS beat(12)11
Avg EPS beat(12)34.1%
EPS beat(16)14
Avg EPS beat(16)30.76%
Revenue beat(2)2
Avg Revenue beat(2)4.21%
Min Revenue beat(2)0.98%
Max Revenue beat(2)7.43%
Revenue beat(4)4
Avg Revenue beat(4)4.87%
Min Revenue beat(4)0.98%
Max Revenue beat(4)7.43%
Revenue beat(8)7
Avg Revenue beat(8)3.66%
Revenue beat(12)11
Avg Revenue beat(12)6.82%
Revenue beat(16)14
Avg Revenue beat(16)5.61%
PT rev (1m)0.66%
PT rev (3m)0.66%
EPS NQ rev (1m)0%
EPS NQ rev (3m)14.83%
EPS NY rev (1m)0%
EPS NY rev (3m)5.68%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)25.61%
Revenue NY rev (1m)-0.28%
Revenue NY rev (3m)4.72%
Valuation
Industry RankSector Rank
PE 36.07
Fwd PE 28.89
P/S 4.2
P/FCF 42.66
P/OCF 35.34
P/B 5.89
P/tB N/A
EV/EBITDA 24.8
EPS(TTM)7.01
EY2.77%
EPS(NY)8.75
Fwd EY3.46%
FCF(TTM)5.93
FCFY2.34%
OCF(TTM)7.15
OCFY2.83%
SpS60.21
BVpS42.91
TBVpS-1.34
PEG (NY)1.23
PEG (5Y)1.59
Profitability
Industry RankSector Rank
ROA 8.49%
ROE 16.47%
ROCE 13.05%
ROIC 10.61%
ROICexc 10.93%
ROICexgc 29.09%
OM 15.83%
PM (TTM) 11.74%
GM 28.31%
FCFM 9.84%
ROA(3y)8.98%
ROA(5y)8.8%
ROE(3y)13.83%
ROE(5y)12.26%
ROIC(3y)9.4%
ROIC(5y)9.46%
ROICexc(3y)9.58%
ROICexc(5y)9.84%
ROICexgc(3y)21.67%
ROICexgc(5y)20.24%
ROCE(3y)11.55%
ROCE(5y)11.63%
ROICexcg growth 3Y23.9%
ROICexcg growth 5Y9.52%
ROICexc growth 3Y17.37%
ROICexc growth 5Y6.42%
OM growth 3Y14.65%
OM growth 5Y5.97%
PM growth 3Y14.56%
PM growth 5Y8.39%
GM growth 3Y4.03%
GM growth 5Y2%
F-Score5
Asset Turnover0.72
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF 4.67
Debt/EBITDA 2.32
Cap/Depr 72.29%
Cap/Sales 2.04%
Interest Coverage 14.27
Cash Conversion 63.72%
Profit Quality 83.86%
Current Ratio 2.57
Quick Ratio 1.43
Altman-Z 5.73
F-Score5
WACC9.15%
ROIC/WACC1.16
Cap/Depr(3y)90.69%
Cap/Depr(5y)79.13%
Cap/Sales(3y)3.04%
Cap/Sales(5y)2.9%
Profit Quality(3y)44.68%
Profit Quality(5y)83.37%
High Growth Momentum
Growth
EPS 1Y (TTM)28.86%
EPS 3Y48.68%
EPS 5Y22.74%
EPS Q2Q%38.82%
EPS Next Y29.29%
EPS Next 2Y22.31%
EPS Next 3Y19.49%
EPS Next 5YN/A
Revenue 1Y (TTM)18.48%
Revenue growth 3Y30.65%
Revenue growth 5Y16%
Sales Q2Q%44.01%
Revenue Next Year27.68%
Revenue Next 2Y22.86%
Revenue Next 3Y17.77%
Revenue Next 5YN/A
EBIT growth 1Y30.99%
EBIT growth 3Y49.79%
EBIT growth 5Y22.92%
EBIT Next Year74.78%
EBIT Next 3Y31.4%
EBIT Next 5YN/A
FCF growth 1Y496.37%
FCF growth 3Y14.27%
FCF growth 5Y14.19%
OCF growth 1Y11575.1%
OCF growth 3Y18.18%
OCF growth 5Y14.16%